Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032 | DelveInsight
DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading ...
Hosted on MSN8h
Multiple states pushing to ban or restrict mRNA vaccines
The "Make America Healthy Again" commission is reviewing certain vaccines as some states push to restrict the use of COVID-19 ...
OpenAI crosses 400M users for ChatGPT amid DeepSeek challenge
Microsoft ( NASDAQ: MSFT )-backed OpenAI had 400 million weekly active users for ChatGPT as of February. It is a 33% increase from the 300 million weekly active users as of Dec. 4, 2024, an OpenAI ...
Revealed: 17,000 Brits may have be killed or injured by Covid jabs
US scientists have discovered an alarming syndrome linked to the most commonly used Covid jab in the UK as the number of ...
Storm of horror winter D&V infections cripples NHS as cases hit all-time high – and experts issue urgent warning
HOSPITALS in England have been hit by a storm of norovirus infections, with cases reaching a record high. As well as bouts of ...
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than one. The healthcare company's innovative Spikevax was one of the go-to vaccines that sped to ...
Royal Bank of Canada Reiterates “Sector Perform” Rating for Moderna (NASDAQ:MRNA)
Moderna (NASDAQ:MRNA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They ...